Pfizer Mobile App Includes $4 Copay Card For Lipitor
This article was originally published in The Pink Sheet Daily
Executive Summary
Pfizer introduces a tool that could help keep the brand in patients’ minds when a flood of generics becomes available in June.
You may also be interested in...
Plavix Takes A Final Bow, But Will It Go Gracefully?
Generic versions of Bristol-Myers Squibb/Sanofi’s blockbuster clot-buster clopidogrel launched in the U.S. May 17, but the companies are helping some patients continue on the brand by covering the high out-of-pocket costs. Following Pfizer’s success retaining share of Lipitor, industry is paying close attention to brand retention programs.
Lipitor Watch: Pfizer Hangs On To Share, But At What Cost?
As the world enters the seventh week of generic atorvastatin, Pfizer has clearly managed to hang on to more share for the brand than it would have under a more traditional, less aggressive strategy. But there was never anything traditional about Lipitor to begin with, so it remains an open question whether another brand firm could reproduce Pfizer’s success, or even its approach, in the face of an exclusivity loss.
GSK's Nucala Is Significantly Overpriced, ICER Draft Report Finds
New biologic for severe asthma doesn't stack up well to standard of care on generally accepted levels of cost per quality-adjusted life year.